DOCSLIB.ORG

Evolution of Vertebrate Opioid Receptors

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Evolution of Vertebrate Opioid Receptors Evolution of vertebrate opioid receptors Susanne Dreborg, Go¨ rel Sundstro¨ m, Tomas A. Larsson, and Dan Larhammar* Department of Neuroscience, Uppsala University, Box 593, SE-75124 Uppsala, Sweden Edited by Tomas Ho¨kfelt, Karolinska Institutet, Stockholm, Sweden, and approved August 15, 2008 (received for review June 9, 2008) The opioid peptides and receptors have prominent roles in pain Many vertebrate gene families have been found to have transmission and reward mechanisms in mammals. The evolution expanded in the early stages of vertebrate evolution, before the of the opioid receptors has so far been little studied, with only a radiation of jawed vertebrates. However, the high degree of few reports on species other than tetrapods. We have investigated sequence divergence over such large evolutionary distances species representing a broader range of vertebrates and found that often obscures orthology–paralogy relationships. Investigation the four opioid receptor types (delta, kappa, mu, and NOP) are of conserved synteny may facilitate identification of orthologs present in most of the species. The gene relationships were and gives important clues to the mechanisms by which the genes deduced by using both phylogenetic analyses and chromosomal were duplicated. We used this approach to investigate the location relative to 20 neighboring gene families in databases of evolution of a few other gene families, namely the neuropeptide assembled genomes. The combined results show that the verte- Y (NPY) family of peptides (27) and the large family of NPY brate opioid receptor gene family arose by quadruplication of a receptors (28). These families were found to have expanded as large chromosomal block containing at least 14 other gene fami- a result of extensive chromosome duplications, most likely lies. The quadruplication seems to coincide with, and, therefore, resulting from two tetraploidizations, i.e., genome duplications, probably resulted from, the two proposed genome duplications in that occurred early in vertebrate evolution (29). These genome early vertebrate evolution. We conclude that the quartet of opioid duplications, often referred to as 1R and 2R, occurred after the receptors was already present at the origin of jawed vertebrates divergence of tunicates and lancelets (30) from vertebrates but Ϸ450 million years ago. A few additional opioid receptor gene before the divergence of cartilaginous fishes and bony verte- duplications have occurred in bony fishes. Interestingly, the brates (31). For the cyclostomes (lampreys and hagfishes) the ancestral receptor gene duplications coincide with the origin of picture is not completely clear but based on analyses of a limited the four opioid peptide precursor genes. Thus, the complete number of gene families they seem to have undergone the first tetraploidization (1R) but not the second (2R) (32–36). vertebrate opioid system was already established in the first As the opioid receptor genes are located on four different jawed vertebrates. chromosomes in human (1, 6, 8, and 20) we decided to investigate whether they arose by duplication of a single ancestral opioid chromosome ͉ G protein-coupled receptor ͉ gene duplication receptor gene in the two tetraploidizations. Other investigators have also suggested that studies of chromosomal location may everal opioid peptides, including endorphin and enkephalins, shed light on opioid receptor evolution (37). We describe here Sare important regulators of nociceptive neurotransmission an investigation, using a combination of sequence-based phy- and reward mechanisms in mammals. Specific binding sites in the logenies and gene locations for the opioid receptors and their brain for opioid compounds were first reported in 1973 (1–3), neighboring families that shows that they expanded by gene and it was soon evident that more than one type of binding site duplications in conjunction with the proposed tetraploidizations existed (4). Subsequently three distinct opioid receptors were in early vertebrate evolution. identified and designated delta, kappa, and mu. These receptors were cloned and found to be encoded by separate genes belong- Results ing to the superfamily of rhodopsin-like G protein-coupled To investigate whether the opioid receptor genes arose by receptors (GPCRs) (5–8). The genes for the opioid receptors duplications of a single ancestral gene in the two basal vertebrate (OPR) have been named OPRD1 (delta), OPRK1 (kappa), and tetraploidizations we have analyzed the opioid receptor gene OPRM1 (mu) by the HUGO Gene Nomenclature Committee family and 20 of the neighboring gene families phylogenetically. (HGNC). Specifically, we wanted to find out whether these gene families Homology searches resulted in the discovery of a fourth were duplicated in the same time period, i.e., after the diver- receptor in both rodents and humans initially named ORL1 for gence of invertebrate chordates and vertebrates but before the opioid receptor-like (9) or LC132 (10). This receptor shows divergence of bony fishes and tetrapods because this is the time 48–49% identity to the other three human receptors, which span in which the two tetraploidizations took place. The gene display 55–58% identity among one another. The receptor has families were analyzed phylogenetically by making both neigh- been named NOP by the International Union of Basic and bor-joining (NJ) trees and quartet-puzzling maximum likelihood Clinical Pharmacology and its gene has been named OPRL1 by (QP) trees in which species that diverged before 2R were used HGNC. An endogenous peptide ligand with some similarity to as outgroups to provide relative dating of the gene duplications. the other opioid peptides was discovered and named nociceptin The opioid receptors were analyzed in human (Homo sapiens), (11) or orphanin FQ (12). mouse (Mus musculus), dog (Canis familiaris), cow (Bos taurus), The evolution of the endogenous opioid peptide ligands has been studied extensively and the major peptide ligands are Author contributions: S.D., G.S., T.A.L., and D.L. designed research; S.D. and G.S. performed generated from four prepropeptides that are encoded by sepa- research; S.D., G.S., T.A.L., and D.L. analyzed data; and S.D., G.S., T.A.L., and D.L. wrote the rate genes in tetrapods. The genes arose by duplications in the paper. common ancestor of tetrapods and bony fishes (13). Opioid The authors declare no conflict of interest. receptor sequences have been reported for a few nonmammalian This article is a PNAS Direct Submission. tetrapods (14–18) and a few teleost fishes (19–24), and a partial *To whom correspondence should be addressed. E-mail: [email protected]. sequence has been reported for a hagfish (19). Functional studies This article contains supporting information online at www.pnas.org/cgi/content/full/ EVOLUTION in amphibians and bony fishes have shown that the opioid system 0805590105/DCSupplemental. is involved in nociception also in these species (25, 26). © 2008 by The National Academy of Sciences of the USA www.pnas.org͞cgi͞doi͞10.1073͞pnas.0805590105 PNAS ͉ October 7, 2008 ͉ vol. 105 ͉ no. 40 ͉ 15487–15492 Downloaded by guest on September 25, 2021 Dme.3L Bfl.sc203 Hsa.17.SSTR2 gray short-tailed opossum (Monodelphis domestica), chicken 63 Hsa.22.SSTR3 (Gallus gallus), western clawed frog (Xenopus tropicalis), rough- Hsa.16.SSTR5 Hsa.20.SSTR4 skinned newt (Taricha granulosa), zebrafish (Danio rerio), 95 Hsa.14.SSTR1 71 Hsa.20.NPBWR2 medaka (Oryzias latipes), stickleback (Gasterosteus aculeatus), NPBWR2 71 Bta.Un.b and spotted green pufferfish (Tetraodon nigroviridis). We found Mdo.1.a* at least four opioid receptor genes in the genome databases for Ola.7 Gac.XII.a most of these species. The zebrafish and medaka have duplicates 65 Dre.23..b of the OPRK1 and/or the OPRD1 genes, whereas the OPRL1 52 Xtr.sc1400.a* Hsa.8.NPBWR1 63 gene is missing in medaka and the OPRM1 gene is missing in Bta.14.b NPBWR1 80 Cfa.29.a spotted green pufferfish [Fig. 1 and supporting information (SI) 66 96 Mmu.1.b Fig. S1]. However, this does not necessarily mean that these Mdo.3.b genes have been lost because their absence may simply be due to 57 Cmi.AAVX01065032.1 Xtr.sc83.a* 84 incomplete sequencing of the genomes or poor genome assembly 66 Gga.2.a in the databases. The human opioid receptor sequences were Pma.co2020 97 Pma.co7520 Hsa.20.OPRL1 used for blastp searches of the Florida lancelet (Branchiostoma 90 Bta.13 floridae) database and the elephant shark (Callorhinchus milii) 94 Cfa.24 91 database, but this produced no reasonable hits. Mmu.2 OPRL1 The phylogenetic tree (Fig. 1) shows that the neuropeptide 76 Mdo.1.b 65 Tgr.L B/W (NPBW) receptors are closely related to the opioid recep- 95 Gga.20 57 Xtr.sc1400.b tors, i.e., closer than to any other GPCRs. This is supported by Dre.23.a 94 Tni.Un.b* the chromosomal locations because NPBWR1 is located next to 99 100 Gac.XII.b OPRK1 on human chromosome 8 (287 kb downstream) and Hsa.8.OPRK1 50 Cfa.29.b NPBWR2 is situated on human chromosome 20 next to OPRL1 91 Bta.14.a 78 (only 26 kb downstream) (Fig. 2 and 3). Such close linkage can Mmu.1.a 98 be seen in most of the species that have NPBW receptors. An Mdo.3.a 97 Gga.2.b OPRK1 earlier split of the somatostatin receptors from the opioid/ Tgr.K NPBW receptors is suggested by the fact that the vertebrate 96 Xtr.sc83.b* 85 Ola.20* somatostatin receptors cluster with a Florida lancelet sequence 91 93 Tni.6* and a fruit fly (Drosophila melanogaster) allostatin C receptor Gac.XXI* 52 Ola.17 sequence in the phylogenetic tree (Fig. 1). Both the opioid and 64 92 95 Gac.III the NPBW receptor families seem to have expanded in the time Tni.Un.a* 85 Dre.2 period coinciding with the tetraploidizations in early vertebrate Hsa.6.OPRM1 62 Cfa.1 evolution.
Load more

Recommended publications
  • Analysis of Trans Esnps Infers Regulatory Network Architecture
    Analysis of trans eSNPs infers regulatory network architecture Anat Kreimer Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2014 © 2014 Anat Kreimer All rights reserved ABSTRACT Analysis of trans eSNPs infers regulatory network architecture Anat Kreimer eSNPs are genetic variants associated with transcript expression levels. The characteristics of such variants highlight their importance and present a unique opportunity for studying gene regulation. eSNPs affect most genes and their cell type specificity can shed light on different processes that are activated in each cell. They can identify functional variants by connecting SNPs that are implicated in disease to a molecular mechanism. Examining eSNPs that are associated with distal genes can provide insights regarding the inference of regulatory networks but also presents challenges due to the high statistical burden of multiple testing. Such association studies allow: simultaneous investigation of many gene expression phenotypes without assuming any prior knowledge and identification of unknown regulators of gene expression while uncovering directionality. This thesis will focus on such distal eSNPs to map regulatory interactions between different loci and expose the architecture of the regulatory network defined by such interactions. We develop novel computational approaches and apply them to genetics-genomics data in human. We go beyond pairwise interactions to define network motifs, including regulatory modules and bi-fan structures, showing them to be prevalent in real data and exposing distinct attributes of such arrangements. We project eSNP associations onto a protein-protein interaction network to expose topological properties of eSNPs and their targets and highlight different modes of distal regulation.
    [Show full text]
  • The in Vitro Binding Properties of Non-Peptide AT1 Receptor Antagonists
    Journal of Clinical and Basic Cardiology An Independent International Scientific Journal Journal of Clinical and Basic Cardiology 2002; 5 (1), 75-82 The In Vitro Binding Properties of Non-Peptide AT1 Receptor Antagonists Vanderheyden PML, Fierens FLP, Vauquelin G, Verheijen I Homepage: www.kup.at/jcbc Online Data Base Search for Authors and Keywords Indexed in Chemical Abstracts EMBASE/Excerpta Medica Krause & Pachernegg GmbH · VERLAG für MEDIZIN und WIRTSCHAFT · A-3003 Gablitz/Austria REVIEWS Binding of Non-Peptide AT1 Receptor Antagonists J Clin Basic Cardiol 2002; 5: 75 The In Vitro Binding Properties of Non-Peptide AT1 Receptor Antagonists P. M. L. Vanderheyden, I. Verheijen, F. L. P. Fierens, G. Vauquelin A major breakthrough in the development of AT1 receptor antagonists as promising antihypertensive drugs, was the synthe- sis of potent and selective non-peptide antagonists for this receptor. In the present manuscript an overview of the in vitro binding properties of these antagonists is discussed. In particular, CHO cells expressing human AT1 receptors offer a well- defined and efficient experimental system, in which antagonist binding and inhibition of angiotensin II induced responses could be measured. From these studies it appeared that all investigated antagonists were competitive with respect to angiotensin II and bind to a common or overlapping binding site on the receptor. Moreover this model allowed us to describe the mecha- nism by which certain antagonists depress the maximal angiotensin II responsiveness in vascular contraction studies. Insur- mountable inhibition was found to be related to the dissociation rate of the antagonist-AT1 receptor complex. The almost complete (candesartan), partially insurmountable inhibition (irbesartan, EXP3174, valsartan) or surmountable inhibition (losartan), was explained by the ability of the antagonist-receptor complex to adopt a fast and slow reversible state.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Supplemental Materials ZNF281 Enhances Cardiac Reprogramming
    Supplemental Materials ZNF281 enhances cardiac reprogramming by modulating cardiac and inflammatory gene expression Huanyu Zhou, Maria Gabriela Morales, Hisayuki Hashimoto, Matthew E. Dickson, Kunhua Song, Wenduo Ye, Min S. Kim, Hanspeter Niederstrasser, Zhaoning Wang, Beibei Chen, Bruce A. Posner, Rhonda Bassel-Duby and Eric N. Olson Supplemental Table 1; related to Figure 1. Supplemental Table 2; related to Figure 1. Supplemental Table 3; related to the “quantitative mRNA measurement” in Materials and Methods section. Supplemental Table 4; related to the “ChIP-seq, gene ontology and pathway analysis” and “RNA-seq” and gene ontology analysis” in Materials and Methods section. Supplemental Figure S1; related to Figure 1. Supplemental Figure S2; related to Figure 2. Supplemental Figure S3; related to Figure 3. Supplemental Figure S4; related to Figure 4. Supplemental Figure S5; related to Figure 6. Supplemental Table S1. Genes included in human retroviral ORF cDNA library. Gene Gene Gene Gene Gene Gene Gene Gene Symbol Symbol Symbol Symbol Symbol Symbol Symbol Symbol AATF BMP8A CEBPE CTNNB1 ESR2 GDF3 HOXA5 IL17D ADIPOQ BRPF1 CEBPG CUX1 ESRRA GDF6 HOXA6 IL17F ADNP BRPF3 CERS1 CX3CL1 ETS1 GIN1 HOXA7 IL18 AEBP1 BUD31 CERS2 CXCL10 ETS2 GLIS3 HOXB1 IL19 AFF4 C17ORF77 CERS4 CXCL11 ETV3 GMEB1 HOXB13 IL1A AHR C1QTNF4 CFL2 CXCL12 ETV7 GPBP1 HOXB5 IL1B AIMP1 C21ORF66 CHIA CXCL13 FAM3B GPER HOXB6 IL1F3 ALS2CR8 CBFA2T2 CIR1 CXCL14 FAM3D GPI HOXB7 IL1F5 ALX1 CBFA2T3 CITED1 CXCL16 FASLG GREM1 HOXB9 IL1F6 ARGFX CBFB CITED2 CXCL3 FBLN1 GREM2 HOXC4 IL1F7
    [Show full text]
  • Atrazine and Cell Death Symbol Synonym(S)
    Supplementary Table S1: Atrazine and Cell Death Symbol Synonym(s) Entrez Gene Name Location Family AR AIS, Andr, androgen receptor androgen receptor Nucleus ligand- dependent nuclear receptor atrazine 1,3,5-triazine-2,4-diamine Other chemical toxicant beta-estradiol (8R,9S,13S,14S,17S)-13-methyl- Other chemical - 6,7,8,9,11,12,14,15,16,17- endogenous decahydrocyclopenta[a]phenanthrene- mammalian 3,17-diol CGB (includes beta HCG5, CGB3, CGB5, CGB7, chorionic gonadotropin, beta Extracellular other others) CGB8, chorionic gonadotropin polypeptide Space CLEC11A AW457320, C-type lectin domain C-type lectin domain family 11, Extracellular growth factor family 11, member A, STEM CELL member A Space GROWTH FACTOR CYP11A1 CHOLESTEROL SIDE-CHAIN cytochrome P450, family 11, Cytoplasm enzyme CLEAVAGE ENZYME subfamily A, polypeptide 1 CYP19A1 Ar, ArKO, ARO, ARO1, Aromatase cytochrome P450, family 19, Cytoplasm enzyme subfamily A, polypeptide 1 ESR1 AA420328, Alpha estrogen receptor,(α) estrogen receptor 1 Nucleus ligand- dependent nuclear receptor estrogen C18 steroids, oestrogen Other chemical drug estrogen receptor ER, ESR, ESR1/2, esr1/esr2 Nucleus group estrone (8R,9S,13S,14S)-3-hydroxy-13-methyl- Other chemical - 7,8,9,11,12,14,15,16-octahydro-6H- endogenous cyclopenta[a]phenanthren-17-one mammalian G6PD BOS 25472, G28A, G6PD1, G6PDX, glucose-6-phosphate Cytoplasm enzyme Glucose-6-P Dehydrogenase dehydrogenase GATA4 ASD2, GATA binding protein 4, GATA binding protein 4 Nucleus transcription TACHD, TOF, VSD1 regulator GHRHR growth hormone releasing
    [Show full text]
  • Opioid Receptorsreceptors
    OPIOIDOPIOID RECEPTORSRECEPTORS defined or “classical” types of opioid receptor µ,dk and . Alistair Corbett, Sandy McKnight and Graeme Genes encoding for these receptors have been cloned.5, Henderson 6,7,8 More recently, cDNA encoding an “orphan” receptor Dr Alistair Corbett is Lecturer in the School of was identified which has a high degree of homology to Biological and Biomedical Sciences, Glasgow the “classical” opioid receptors; on structural grounds Caledonian University, Cowcaddens Road, this receptor is an opioid receptor and has been named Glasgow G4 0BA, UK. ORL (opioid receptor-like).9 As would be predicted from 1 Dr Sandy McKnight is Associate Director, Parke- their known abilities to couple through pertussis toxin- Davis Neuroscience Research Centre, sensitive G-proteins, all of the cloned opioid receptors Cambridge University Forvie Site, Robinson possess the same general structure of an extracellular Way, Cambridge CB2 2QB, UK. N-terminal region, seven transmembrane domains and Professor Graeme Henderson is Professor of intracellular C-terminal tail structure. There is Pharmacology and Head of Department, pharmacological evidence for subtypes of each Department of Pharmacology, School of Medical receptor and other types of novel, less well- Sciences, University of Bristol, University Walk, characterised opioid receptors,eliz , , , , have also been Bristol BS8 1TD, UK. postulated. Thes -receptor, however, is no longer regarded as an opioid receptor. Introduction Receptor Subtypes Preparations of the opium poppy papaver somniferum m-Receptor subtypes have been used for many hundreds of years to relieve The MOR-1 gene, encoding for one form of them - pain. In 1803, Sertürner isolated a crystalline sample of receptor, shows approximately 50-70% homology to the main constituent alkaloid, morphine, which was later shown to be almost entirely responsible for the the genes encoding for thedk -(DOR-1), -(KOR-1) and orphan (ORL ) receptors.
    [Show full text]
  • An Integrative, Genomic, Transcriptomic and Network-Assisted
    Yan et al. BMC Medical Genomics 2020, 13(Suppl 5):39 https://doi.org/10.1186/s12920-020-0675-4 RESEARCH Open Access An integrative, genomic, transcriptomic and network-assisted study to identify genes associated with human cleft lip with or without cleft palate Fangfang Yan1†, Yulin Dai1†, Junichi Iwata2,3, Zhongming Zhao1,4,5* and Peilin Jia1* From The International Conference on Intelligent Biology and Medicine (ICIBM) 2019 Columbus, OH, USA. 9-11 June 2019 Abstract Background: Cleft lip with or without cleft palate (CL/P) is one of the most common congenital human birth defects. A combination of genetic and epidemiology studies has contributed to a better knowledge of CL/P-associated candidate genes and environmental risk factors. However, the etiology of CL/P remains not fully understood. In this study, to identify new CL/P-associated genes, we conducted an integrative analysis using our in-house network tools, dmGWAS [dense module search for Genome-Wide Association Studies (GWAS)] and EW_dmGWAS (Edge-Weighted dmGWAS), in a combination with GWAS data, the human protein-protein interaction (PPI) network, and differential gene expression profiles. Results: A total of 87 genes were consistently detected in both European and Asian ancestries in dmGWAS. There were 31.0% (27/87) showed nominal significance with CL/P (gene-based p < 0.05), with three genes showing strong association signals, including KIAA1598, GPR183,andZMYND11 (p <1×10− 3). In EW_dmGWAS, we identified 253 and 245 module genes associated with CL/P for European ancestry and the Asian ancestry, respectively. Functional enrichment analysis demonstrated that these genes were involved in cell adhesion, protein localization to the plasma membrane, the regulation of the apoptotic signaling pathway, and other pathological conditions.
    [Show full text]
  • Constitutive Activation of G Protein-Coupled Receptors and Diseases: Insights Into Mechanisms of Activation and Therapeutics
    Pharmacology & Therapeutics 120 (2008) 129–148 Contents lists available at ScienceDirect Pharmacology & Therapeutics journal homepage: www.elsevier.com/locate/pharmthera Associate editor: S. Enna Constitutive activation of G protein-coupled receptors and diseases: Insights into mechanisms of activation and therapeutics Ya-Xiong Tao ⁎ Department of Anatomy, Physiology and Pharmacology, 212 Greene Hall, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA article info abstract The existence of constitutive activity for G protein-coupled receptors (GPCRs) was first described in 1980s. In Keywords: 1991, the first naturally occurring constitutively active mutations in GPCRs that cause diseases were reported G protein-coupled receptor Disease in rhodopsin. Since then, numerous constitutively active mutations that cause human diseases were reported Constitutively active mutation in several additional receptors. More recently, loss of constitutive activity was postulated to also cause Inverse agonist diseases. Animal models expressing some of these mutants confirmed the roles of these mutations in the Mechanism of activation pathogenesis of the diseases. Detailed functional studies of these naturally occurring mutations, combined Transgenic model with homology modeling using rhodopsin crystal structure as the template, lead to important insights into the mechanism of activation in the absence of crystal structure of GPCRs in active state. Search for inverse Abbreviations: agonists on these receptors will be critical for correcting the diseases cause by activating mutations in GPCRs. ADRP, autosomal dominant retinitis pigmentosa Theoretically, these inverse agonists are better therapeutics than neutral antagonists in treating genetic AgRP, Agouti-related protein AR, adrenergic receptor diseases caused by constitutively activating mutations in GPCRs. CAM, constitutively active mutant © 2008 Elsevier Inc.
    [Show full text]
  • Identification of Transcriptomic Differences Between Lower
    International Journal of Molecular Sciences Article Identification of Transcriptomic Differences between Lower Extremities Arterial Disease, Abdominal Aortic Aneurysm and Chronic Venous Disease in Peripheral Blood Mononuclear Cells Specimens Daniel P. Zalewski 1,*,† , Karol P. Ruszel 2,†, Andrzej St˛epniewski 3, Dariusz Gałkowski 4, Jacek Bogucki 5 , Przemysław Kołodziej 6 , Jolanta Szyma ´nska 7 , Bartosz J. Płachno 8 , Tomasz Zubilewicz 9 , Marcin Feldo 9,‡ , Janusz Kocki 2,‡ and Anna Bogucka-Kocka 1,‡ 1 Chair and Department of Biology and Genetics, Medical University of Lublin, 4a Chod´zkiSt., 20-093 Lublin, Poland; [email protected] 2 Chair of Medical Genetics, Department of Clinical Genetics, Medical University of Lublin, 11 Radziwiłłowska St., 20-080 Lublin, Poland; [email protected] (K.P.R.); [email protected] (J.K.) 3 Ecotech Complex Analytical and Programme Centre for Advanced Environmentally Friendly Technologies, University of Marie Curie-Skłodowska, 39 Gł˛ebokaSt., 20-612 Lublin, Poland; [email protected] 4 Department of Pathology and Laboratory Medicine, Rutgers-Robert Wood Johnson Medical School, One Robert Wood Johnson Place, New Brunswick, NJ 08903-0019, USA; [email protected] 5 Chair and Department of Organic Chemistry, Medical University of Lublin, 4a Chod´zkiSt., Citation: Zalewski, D.P.; Ruszel, K.P.; 20-093 Lublin, Poland; [email protected] St˛epniewski,A.; Gałkowski, D.; 6 Laboratory of Diagnostic Parasitology, Chair and Department of Biology and Genetics, Medical University of Bogucki, J.; Kołodziej, P.; Szyma´nska, Lublin, 4a Chod´zkiSt., 20-093 Lublin, Poland; [email protected] J.; Płachno, B.J.; Zubilewicz, T.; Feldo, 7 Department of Integrated Paediatric Dentistry, Chair of Integrated Dentistry, Medical University of Lublin, M.; et al.
    [Show full text]
  • Research Article Identification of Microrna-451A As a Novel Circulating Biomarker for Colorectal Cancer Diagnosis
    Hindawi BioMed Research International Volume 2020, Article ID 5236236, 18 pages https://doi.org/10.1155/2020/5236236 Research Article Identification of microRNA-451a as a Novel Circulating Biomarker for Colorectal Cancer Diagnosis Zhen Zhang ,1 Dai Zhang,2 Yaping Cui,1 Yongsheng Qiu,3 Changhong Miao,4 and Xihua Lu 1 1Department of Anesthesiology, Affiliated Cancer Hospital of ZhengZhou University, Henan Cancer Hospital, ZhengZhou, China 2Department of Laboratory Medicine, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, China 3Department of Anesthesiology, Children’s Hospital Affiliated to Zhengzhou University, Zhengzhou, China 4Department of Anesthesiology, Affiliated Cancer Hospital of Fudan University, Shanghai, China Correspondence should be addressed to Zhen Zhang; [email protected] and Xihua Lu; [email protected] Received 3 July 2020; Accepted 10 August 2020; Published 27 August 2020 Academic Editor: David A. McClellan Copyright © 2020 Zhen Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. Colorectal cancer (CRC) is one of the leading causes of cancer death worldwide. Successful treatment of CRC relies on accurate early diagnosis, which is currently a challenge due to its complexity and personalized pathologies. Thus, novel molecular biomarkers are needed for early CRC detection. Methods. Gene and microRNA microarray profiling of CRC tissues and miRNA- seq data were analyzed. Candidate microRNA biomarkers were predicted using both CRC-specific network and miRNA-BD tool. Validation analyses were carried out to interrogate the identified candidate CRC biomarkers.
    [Show full text]
  • Identifying Compartment-Specific Non-HLA Targets After Renal Transplantation by Integrating Transcriptome and ‘‘Antibodyome’’ Measures
    Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and ‘‘antibodyome’’ measures Li Lia, Persis Wadiab, Rong Chenc, Neeraja Kambhamd, Maarten Naesensa, Tara K. Sigdela, David B. Miklosb, Minnie M. Sarwala,1, and Atul J. Buttea,c,1 aDepartment of Pediatrics, Blood and Marrow Transplantation Division, Departments of bMedicine and dPathology, and cCenter for Biomedical Informatics Research, Stanford University, 300 Pasteur Drive, Stanford, CA 94304 Communicated by Mark M. Davis, Stanford University School of Medicine, Stanford, CA, January 27, 2009 (received for review May 22, 2008) We have conducted an integrative genomics analysis of serological antigens, may be associated with chronic renal allograft histological responses to non-HLA targets after renal transplantation, with the injury (11). Antibodies against Agrin, the most abundant heparin aim of identifying the tissue specificity and types of immunogenic sulfate proteoglycan present in the glomerular basal membrane, non-HLA antigenic targets after transplantation. Posttransplant have been implicated in transplant glomerulopathy (12), and ago- antibody responses were measured by paired comparative analysis nistic antibodies against the Angiotensin II type 1 receptor of pretransplant and posttransplant serum samples from 18 pedi- (AT1R-AA) were described in renal allograft recipients with severe atric renal transplant recipients, measured against 5,056 unique vascular types of rejection and malignant hypertension (13). protein targets on the ProtoArray platform. The specificity of It is expected that there are many more unidentified non-HLA antibody responses were measured against gene expression levels non-ABO immune antigens that might evoke specific antibody specific to the kidney, and 2 other randomly selected organs (heart responses after renal transplantation (8).
    [Show full text]
  • Systematic Screening Reveals a Role for BRCA1 in the Response to Transcription-Associated DNA Damage
    Downloaded from genesdev.cshlp.org on October 6, 2021 - Published by Cold Spring Harbor Laboratory Press RESOURCE/METHODOLOGY Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage Sarah J. Hill,1,2 Thomas Rolland,1,2,3 Guillaume Adelmant,1,4,5 Xianfang Xia,1,2,3 Matthew S. Owen,1,2,3 Amelie Dricot,1,2,3 Travis I. Zack,1,6 Nidhi Sahni,1,2,3 Yves Jacob,1,2,3,7,8,9 Tong Hao,1,2,3 Kristine M. McKinney,1,2 Allison P. Clark,1,2 Deepak Reyon,10,11,12 Shengdar Q. Tsai,10,11,12 J. Keith Joung,10,11,12 Rameen Beroukhim,1,6,13 Jarrod A. Marto,1,4,5 Marc Vidal,1,2,3 Suzanne Gaudet,1,2,3 David E. Hill,1,2,3,14 and David M. Livingston1,2,14 1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA; 2Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA; 3Center for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA; 4Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA; 5Blais Proteomics Center, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA; 6The Broad Institute, Cambridge, Massachusetts 02142, USA; 7Departement de Virologie, Unite de Gen etique Moleculaire des Virus a ARN, Institut Pasteur, F-75015 Paris, France; 8UMR3569, Centre National de la Recherche Scientifique, F-75015 Paris, France; 9UnitedeG en etique Moleculaire des Virus a ARN, Universite Paris Diderot, F-75015 Paris, France; 10Molecular Pathology Unit, Center for Computational and Integrative Biology, 11Center for Cancer Research, Massachusetts General Hospital, Charlestown, Massachusetts 02129, USA; 12Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115, USA; 13Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA BRCA1 is a breast and ovarian tumor suppressor.
    [Show full text]